FTY 720 for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where FTY 720 was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for FTY 720
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Lymphocyte count decreased | 10 | 9.4% | 0 | 5 |
| Basal cell carcinoma | 8 | 7.5% | 0 | 1 |
| Central nervous system lesion | 7 | 6.5% | 0 | 3 |
| Gamma-glutamyltransferase increased | 7 | 6.5% | 1 | 3 |
| Multiple sclerosis relapse | 7 | 6.5% | 0 | 4 |
| Pyrexia | 6 | 5.6% | 0 | 4 |
| Alanine aminotransferase increased | 5 | 4.7% | 0 | 2 |
| Aspartate aminotransferase increased | 5 | 4.7% | 0 | 2 |
| Hepatic enzyme increased | 5 | 4.7% | 1 | 1 |
Other Indications for FTY 720
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)